NICE technology appraisal guidance
Issued: November 2011
TA237

Ranibizumab for the treatment of diabetic macular oedema

This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta237

Important information about this guidance

This guidance has been updated and replaced by NICE technology appraisal guidance 274.